SNCA and Parkinson disease: However, in the widely used mouse model of PD based on the systemic administration of the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), the mRNA level of α-synuclein is clearly increased in the SN [20, 21].